BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ko SW, Yoon SB. Clinical implications and perspectives of portal venous circulating tumor cells in pancreatic cancer. World J Gastrointest Oncol 2023; 15(4): 632-643 [PMID: 37123055 DOI: 10.4251/wjgo.v15.i4.632]
URL: https://www.wjgnet.com/1007-9327/full/v15/i4/632.htm
Number Citing Articles
1
Zhixian Zhu, Yixuan Zhang, Wenjun Zhang, Dezhi Tang, Song Zhang, Lei Wang, Xiaoping Zou, Zhonghua Ni, Shu Zhang, Ying Lv, Nan Xiang. High-throughput enrichment of portal venous circulating tumor cells for highly sensitive diagnosis of CA19-9-negative pancreatic cancer patients using inertial microfluidicsBiosensors and Bioelectronics 2024; 259: 116411 doi: 10.1016/j.bios.2024.116411
2
Stephanie N. Shishido, Divya Suresh, George Courcoubetis, Brandon Ye, Emmeline Lin, Jeremy Mason, Ken Park, Michael Lewis, Ruoxiang Wang, Simon K. Lo, Peter Kuhn, Stephen Pandol. Determining the efficacy of ExThera Seraph100 blood filtration in patients diagnosed with pancreatic cancer through the liquid biopsyBJC Reports 2024; 2(1) doi: 10.1038/s44276-024-00069-3
3
Taha M. Ahmed, Satomi Kawamoto, Felipe Lopez-Ramirez, Mohammad Yasrab, Ralph H. Hruban, Elliot K. Fishman, Linda C. Chu. Early detection of pancreatic cancer in the era of precision medicineAbdominal Radiology 2024;  doi: 10.1007/s00261-024-04358-w
4
Satoru Miyahara, Hidenori Takahashi, Yoshito Tomimaru, Shogo Kobayashi, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Hirofumi Akita, Takehiro Noda, Yuichiro Doki, Hidetoshi Eguchi. Organ-specific variations in tumor marker dynamics in postoperative pancreatic cancer recurrence: Trends in lung and liver recurrence highlighting biological heterogeneitySurgical Oncology 2024; 55: 102103 doi: 10.1016/j.suronc.2024.102103